BKEMV Trademark

Trademark Overview

On Wednesday, January 26, 2022, a trademark application was filed for BKEMV with the United States Patent and Trademark Office. The USPTO has given the BKEMV trademark a serial number of 97240377. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, June 23, 2025. This trademark is owned by Amgen Inc.. The BKEMV trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, blood cell and blood vessel diseases and disorders
bkemv

General Information

Serial Number97240377
Word MarkBKEMV
Filing DateWednesday, January 26, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, June 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, blood cell and blood vessel diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateWednesday, April 2, 2025
First Use In Commerce DateWednesday, April 2, 2025

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Saturday, January 29, 2022NEW APPLICATION ENTERED
Thursday, April 14, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2022SOU EXTENSION 1 FILED
Monday, December 12, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 18, 2023SOU EXTENSION 2 FILED
Tuesday, July 18, 2023SOU EXTENSION 2 GRANTED
Thursday, July 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2024SOU EXTENSION 3 FILED
Monday, January 8, 2024SOU EXTENSION 3 GRANTED
Wednesday, January 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024SOU EXTENSION 4 FILED
Monday, June 3, 2024SOU EXTENSION 4 GRANTED
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 6, 2025SOU EXTENSION 5 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 11, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 16, 2025SOU EXTENSION 5 GRANTED
Tuesday, April 29, 2025USE AMENDMENT FILED
Tuesday, April 29, 2025TEAS STATEMENT OF USE RECEIVED
Monday, January 6, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, April 16, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 23, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 23, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, May 3, 2025STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

bkemv blood cell vessel diseases disorders autoimmune preparations substances treatment hematological